The FDA warns Novo Nordisk, flaws in reporting side effects of Ozempic and Wegovy

The American authority notes alleged gaps in procedures for adverse reactions in the use of drugs for diabetes and obesity. The Danish giant launches a plan to correct course

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

la-repubblicaItalian169d ago

L’Fda avverte Novo Nordisk, falle nella segnalazione degli effetti collaterali di Ozempic e Wegovy

L’autorità americana rileva presunte lacune nelle procedure sulle reazioni avverse nell’uso dei farmaci contro diabete e obesità. Il colosso danese vara un piano per correggere il tiro

Read full article →

PERSPECTA

PERSPECTA

The FDA warns Novo Nordisk, flaws in reporting side effects of Ozempic and Wegovy

Sources

L’Fda avverte Novo Nordisk, falle nella segnalazione degli effetti collaterali di Ozempic e Wegovy

Related Stories

U.S. FDA Approves Landmark Pancreatic Cancer Drug With Improved Survival Rates

Australian Woman Gives Birth to Twins Fathered by Two Different Men

North Macedonia Reports New West Nile Virus Fatality Amid Enhanced Surveillance

Germany Reports Record 15,800 Heat-Related Deaths This Summer

PERSPECTA